By Tony Fong

Lance Liotta and Emanuel Petricoin have launched a clinical trial using technology they developed to test whether the cancer drug Gleevec can be used to treat colorectal cancer, in what they said it is one of the first applications of proteomics technology for personalized medicine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.